We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.51B
AUM Growth
+$157M
(+12%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
8.67%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
93
New
19
Increased
39
Reduced
13
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CUTR
Cutera, Inc.
CUTR
|
+$36.8M |
| 2 |
Aldeyra Therapeutics
ALDX
|
+$30.2M |
| 3 |
Sutro Biopharma
STRO
|
+$29.2M |
| 4 |
NeoGenomics
NEO
|
+$25.3M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$86.4M |
| 2 |
CareDx
CDNA
|
+$44.6M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$26.6M |
| 4 |
Halozyme
HALO
|
+$25.6M |
| 5 |
Arrowhead Research
ARWR
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.27% |
| 2 | Communication Services | 4.55% |
| 3 | Energy | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
26
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24M | 1.59% |
346,274
+24,307
| +8% | +$1.87M |
|
27
SI-BONE Inc
SIBN
$788M
| $22.3M | 1.48% |
701,732
+27,750
| +4% | +$854K |
|
|
LITS
28
Lite Strategy Inc
LITS
$32.8M
| $21.9M | 1.45% |
318,947
+129,283
| +68% | +$9.04M |
|
29
KORU Medical Systems
KRMD
$189M
| $19.3M | 1.28% |
5,485,238
-386,126
| -7% | -$1.67M |
|
|
APTO
30
DELISTED
Aptose Biosciences, Inc.
APTO
| $18.5M | 1.23% |
6,895
+5,030
| +270% | +$9.97M |
|
|
TCRR
31
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $18.2M | 1.21% |
+826,474
| New | +$22.5M |
|
32
Maravai LifeSciences
MRVI
$969M
| $17.5M | 1.16% |
491,049
+122,849
| +33% | +$4.07M |
|
|
AXNX
33
DELISTED
Axonics, Inc. Common Stock
AXNX
| $16.9M | 1.12% |
+281,528
| New | +$15.3M |
|
34
Codexis
CDXS
$151M
| $16.1M | 1.07% |
704,186
-258,405
| -27% | -$6.05M |
|
35
BioXcel Therapeutics
BTAI
$24.9M
| $15.5M | 1.03% |
22,402
+16,514
| +280% | +$13.3M |
|
36
Neuronetics
STIM
$138M
| $14.2M | 0.94% |
+1,149,777
| New | +$17.6M |
|
37
QuidelOrtho
QDEL
$1.14B
| $14.1M | 0.93% |
110,170
+45,484
| +70% | +$8.4M |
|
38
Alphatec Holdings
ATEC
$1.46B
| $12M | 0.79% |
756,989
+624,489
| +471% | +$9.83M |
|
39
OrthoPediatrics
KIDS
$519M
| $11.1M | 0.74% |
227,450
-53,027
| -19% | -$2.55M |
|
40
The Joint Corp
JYNT
$118M
| $10.5M | 0.7% |
218,085
+23,980
| +12% | +$899K |
|
|
NVTA
41
DELISTED
Invitae Corporation
NVTA
| $9.65M | 0.64% |
+252,442
| New | +$11.5M |
|
|
ITMR
42
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $8.98M | 0.6% |
+375,000
| New | +$8.92M |
|
43
Jazz Pharmaceuticals
JAZZ
$15.9B
| $8.79M | 0.58% |
53,484
+1,522
| +3% | +$250K |
|
|
AKU
44
DELISTED
Akumin Inc
AKU
| $7.38M | 0.49% |
+1,994,200
| New | +$6.72M |
|
|
TPTX
45
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $5.57M | 0.37% |
58,879
+3,198
| +6% | +$380K |
|
46
Simulations Plus
SLP
$369M
| $4.68M | 0.31% |
74,080
+2,361
| +3% | +$173K |
|
47
Zymeworks
ZYME
$1.61B
| $3.72M | 0.25% |
117,848
-79,854
| -40% | -$3.25M |
|
|
LHCG
48
DELISTED
LHC Group LLC
LHCG
| $2.96M | 0.2% |
15,500
+821
| +6% | +$164K |
|
|
SIEN
49
DELISTED
Sientra, Inc.
SIEN
| $2.19M | 0.15% |
+30,000
| New | +$1.91M |
|
50
Quanterix
QTRX
$164M
| $1.58M | 0.11% |
+27,100
| New | +$1.83M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, First Light Asset Management held 93 positions worth $1.51B, up 12% from $1.35B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Light Asset Management deployed $131M of net new capital in Q1 2021, opening 19 new positions and adding to 39 existing holdings. Its largest new stake was Cutera, Inc.: 1,244,117 shares worth $37.4M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 86% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was CareDx, an estimated $44.6M trimmed.
- First Light Asset Management's largest Q1 2021 buy was Cutera, Inc.: 1,244,117 shares worth $37.4M.
- First Light Asset Management added most to Sutro Biopharma in Q1 2021, an estimated $29.2M increase.
- First Light Asset Management's biggest Q1 2021 reduction was CareDx, cutting an estimated $44.6M.
- First Light Asset Management fully exited Oxford Immunotec Global PLC Ordinary Shares in Q1 2021, selling an estimated $86.4M.
- First Light Asset Management's ten largest holdings make up 43% of its $1.51B portfolio in Q1 2021.
- First Light Asset Management opened 19 new positions and closed 16 in Q1 2021.
- First Light Asset Management's portfolio value rose 12% quarter-over-quarter to $1.51B.
Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.